Abstract
Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have been described. One vector that has become very popular for the purpose of cancer gene therapy is adenovirus. Main reasons are that the recombinant adenoviruses expressing the foreign therapeutic genes can be easily generated, and that the infection of the target cells with the recombinant adenoviruses produces large quantities of the therapeutic proteins. The review describes the basic characteristics and the molecular biology of adenoviruses. This review further describes various methods to generate the recombinant adenoviruses. These include the methods to generate the first generation adenoviruses (E1 deleted), up to the most recently used gutless viruses (with complete viral deletions). A critical compari son of the advantages and disadvantages of various methods is also described. The review also describes the use of adenoviruses which selectively replicate in cancer cells. The review further describes the various approaches for cancer gene therapy currently being exploited. These include the gene replacement strategies using tumor suppressor genes, anti-oncogenes, use of suicide genes, immunomodulation and anti-angiogenesis approaches. An in depth analysis of the pre-clinical data obtained using adenoviral vectors for these cancer gene therapy approaches is also described. The review concludes with a critical discussion of the adenoviruses for cancer gene therapy.
Keywords: adenovirus, adenoviral vector, cancer gene therapy, foreign cdna, viral vector
Current Genomics
Title: Adenoviral Vectors for Cancer Gene Therapy
Volume: 3 Issue: 3
Author(s): Wenli Zhao, Masanobu Kobayashi, Masuo Hosokawa and Prem Seth
Affiliation:
Keywords: adenovirus, adenoviral vector, cancer gene therapy, foreign cdna, viral vector
Abstract: Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have been described. One vector that has become very popular for the purpose of cancer gene therapy is adenovirus. Main reasons are that the recombinant adenoviruses expressing the foreign therapeutic genes can be easily generated, and that the infection of the target cells with the recombinant adenoviruses produces large quantities of the therapeutic proteins. The review describes the basic characteristics and the molecular biology of adenoviruses. This review further describes various methods to generate the recombinant adenoviruses. These include the methods to generate the first generation adenoviruses (E1 deleted), up to the most recently used gutless viruses (with complete viral deletions). A critical compari son of the advantages and disadvantages of various methods is also described. The review also describes the use of adenoviruses which selectively replicate in cancer cells. The review further describes the various approaches for cancer gene therapy currently being exploited. These include the gene replacement strategies using tumor suppressor genes, anti-oncogenes, use of suicide genes, immunomodulation and anti-angiogenesis approaches. An in depth analysis of the pre-clinical data obtained using adenoviral vectors for these cancer gene therapy approaches is also described. The review concludes with a critical discussion of the adenoviruses for cancer gene therapy.
Export Options
About this article
Cite this article as:
Zhao Wenli, Kobayashi Masanobu, Hosokawa Masuo and Seth Prem, Adenoviral Vectors for Cancer Gene Therapy, Current Genomics 2002; 3 (3) . https://dx.doi.org/10.2174/1389202023350516
DOI https://dx.doi.org/10.2174/1389202023350516 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Histopathological Determinants of Tumor Resistance: A Special Look to the Immunohistochemical Expression of Carbonic Anhydrase IX in Human Cancers
Current Medicinal Chemistry Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals Vinorelbine in Cancer Therapy
Current Drug Targets Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Estrogen(s) and Analogs as a Non-Immunogenic Endogenous Ligand in Targeted Drug/DNA Delivery
Current Medicinal Chemistry Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Current Drug Targets Curcumin and its Formulations: Potential Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Overcoming Endocrine Resistance in Breast Cancer
Current Cancer Drug Targets Small Molecule Complementarity As A Source of Novel Pharmaceutical Agents and Combination Therapies
Current Pharmaceutical Design Combining Gene Therapy and Radiation Against Cancer
Current Gene Therapy A Historical Overview of the Heterologous Expression of Mammalian UDP-Glucuronosyltransferase Isoforms Over the Past Twenty Years
Current Drug Metabolism The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation
Current Pharmaceutical Biotechnology Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations
Current Pharmaceutical Design DNA Methyltransferases Inhibitors from Natural Sources
Current Topics in Medicinal Chemistry Recent Progress in Discovery and Development of Antimitotic Agents
Anti-Cancer Agents in Medicinal Chemistry Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Current Pharmaceutical Design Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Current Medicinal Chemistry